| AstraZeneca PLC (AZN) |
GB |
$217.304B |
16.22 |
| Amgen Inc. (AMGN) |
US |
$148.321B |
13.29 |
| Gilead Sciences (GILD) |
United States |
$121.877B |
12.65 |
| Vertex Pharmaceuticals (VRTX) |
United States |
$115.694B |
0.00 |
| Bristol Myers Squibb Company (BMY) |
US |
$96.911B |
6.49 |
| CSL (CSLLY) |
Australia |
$78.384B |
0.00 |
| GSK (GSK) |
United Kingdom |
$77.371B |
9.19 |
| Regeneron Pharmaceuticals (REGN) |
United States |
$61.060B |
14.64 |
| argenex SE (ARGX) |
NL |
$38.036B |
261.73 |
| Alnylam Pharmaceuticals, Inc. (ALNY) |
US |
$36.059B |
0.00 |
| BeiGene (ONC) |
Cayman Islands |
$23.912B |
0.00 |
| BioNTech SE Sponsored ADR (BNTX) |
DE |
$22.269B |
0.00 |
| Biogen Inc. (BIIB) |
US |
$17.175B |
7.41 |
| Genmab (GNMSF) |
Denmark |
$13.687B |
14.10 |
| Genmab (GMAB) |
Denmark |
$13.093B |
16.47 |
| Insmed (INSM) |
United States |
$12.340B |
0.00 |
| Illumina (ILMN) |
United States |
$11.795B |
30.42 |
| Incyte (INCY) |
United States |
$11.539B |
87.66 |
| BioMarin Pharmaceutical Inc. (BMRN) |
US |
$11.376B |
18.48 |
| Swedish Orphan Biovitrum (BIOVF) |
SE |
$10.858B |
27.73 |
| Exact Sciences (EXAS) |
United States |
$10.185B |
0.00 |
| Exelixis (EXEL) |
United States |
$10.158B |
21.06 |
| Ascendis Pharma A/S (ASND) |
DK |
$9.816B |
0.00 |
| Moderna (MRNA) |
United States |
$9.448B |
0.00 |
| QIAGEN (QGEN) |
Netherlands |
$9.374B |
18.87 |
| Roivant Sciences (ROIV) |
United Kingdom |
$7.892B |
0.00 |
| Bio-Techne Corp (TECH) |
United States |
$7.544B |
28.92 |
| Halozyme Therapeutics (HALO) |
United States |
$7.335B |
14.01 |
| Repligen (RGEN) |
United States |
$7.322B |
82.01 |
| Revolution Medicines (RVMD) |
United States |
$6.974B |
0.00 |
| Jazz Pharmaceuticals (JAZZ) |
Ireland |
$6.852B |
6.61 |
| Bio-Rad Laboratories, Inc. (BIO.B) |
US |
$6.566B |
22.20 |
| Blueprint Medicines Corporation (BPMC) |
US |
$6.445B |
0.00 |
| Telix Pharmaceuticals (TLX) |
Australia |
$6.176B |
0.00 |
| Verona Pharma American Depositary Share (VRNA) |
United Kingdom |
$5.954B |
0.00 |
| Legend Biotech (LEGN) |
United States |
$5.761B |
0.00 |
| ADMA Biologics Inc (ADMA) |
US |
$5.610B |
42.16 |
| TG Therapeutics (TGTX) |
United States |
$5.535B |
145.25 |
| Axsome Therapeutics, Inc. (AXSM) |
US |
$5.458B |
0.00 |
| Guardant Health (GH) |
United States |
$5.195B |
0.00 |
| Zealand Pharma (ZLDPF) |
Denmark |
$5.012B |
0.00 |
| Alkermes plc (ALKS) |
IE |
$5.010B |
13.44 |
| Nuvalent (NUVL) |
United States |
$4.882B |
0.00 |
| Sarepta Therapeutics (SRPT) |
United States |
$4.594B |
0.00 |
| Cytokinetics (CYTK) |
United States |
$4.049B |
0.00 |
| Krystal Biotech (KRYS) |
United States |
$4.030B |
31.06 |
| Rhythm Pharmaceuticals (RYTM) |
United States |
$3.988B |
0.00 |
| Vaxcyte (PCVX) |
United States |
$3.772B |
0.00 |
| SpringWorks Therapeutics (SWTX) |
United States |
$3.461B |
0.00 |
| Akero Therapeutics, Inc. (AKRO) |
US |
$3.409B |
0.00 |
| Ultragenyx Pharmaceutical (RARE) |
United States |
$3.292B |
0.00 |
| Zai Lab (ZLAB) |
China |
$3.241B |
0.00 |
| Avidity Biosciences (RNA) |
United States |
$3.165B |
0.00 |
| Viking Therapeutics (VKTX) |
United States |
$3.033B |
0.00 |
| Arcellx, Inc. (ACLX) |
US |
$2.916B |
0.00 |
| PTC Therapeutics (PTCT) |
United States |
$2.868B |
0.00 |
| CRISPR Therapeutics AG (CRSP) |
Switzerland |
$2.864B |
0.00 |
| Scholar Rock Holding (SRRK) |
United States |
$2.780B |
0.00 |
| Merus (MRUS) |
Netherlands |
$2.729B |
0.00 |
| Xenon Pharmaceuticals (XENE) |
Canada |
$2.695B |
0.00 |
| Protagonist Therapeutics (PTGX) |
United States |
$2.603B |
56.01 |
| HUTCHMED (China) (HCM) |
Hong Kong, SAR China |
$2.589B |
0.00 |
| MoonLake Immunotherapeutics (MLTX) |
Switzerland |
$2.513B |
0.00 |
| ACADIA Pharmaceuticals Inc. (ACAD) |
US |
$2.478B |
21.78 |
| Alvotech (ALVO) |
LU |
$2.394B |
13.69 |
| Metsera (MTSR) |
United States |
$2.389B |
0.00 |
| Immunovant (IMVT) |
United States |
$2.351B |
0.00 |
| Apellis Pharmaceuticals, Inc. (APLS) |
US |
$2.261B |
0.00 |
| Ascentage Pharma Group International - Unsponsored ADR (AAPG) |
CN |
$2.104B |
0.00 |
| Denali Therapeutics (DNLI) |
United States |
$2.029B |
0.00 |
| Mirum Pharmaceuticals (MIRM) |
United States |
$2.028B |
0.00 |
| Ligand Pharmaceuticals (LGND) |
United States |
$1.992B |
0.00 |
| Regencell Bioscience Holdings (RGC) |
Hong Kong, SAR China |
$1.965B |
0.00 |
| Twist Bioscience (TWST) |
United States |
$1.962B |
0.00 |
| Kiniksa Pharmaceuticals (KNSA) |
United Kingdom |
$1.957B |
0.00 |
| Belite Bio, Inc. Sponsored ADR (BLTE) |
US |
$1.953B |
0.00 |
| Tarsus Pharmaceuticals (TARS) |
United States |
$1.952B |
0.00 |
| Biohaven Ltd. (BHVN) |
US |
$1.941B |
0.00 |
| Vericel (VCEL) |
United States |
$1.928B |
213.61 |
| Amicus Therapeutics (FOLD) |
United States |
$1.906B |
206.33 |
| Kymera Therapeutics (KYMR) |
United States |
$1.860B |
0.00 |
| Certara, Inc. (CERT) |
US |
$1.859B |
34.73 |
| Bavarian Nordic (BVNRY) |
DK |
$1.850B |
13.03 |
| Harmony Biosciences Holdings (HRMY) |
United States |
$1.839B |
12.23 |
| NovoCure (NVCR) |
Jersey |
$1.821B |
0.00 |
| Arrowhead Pharmaceuticals, Inc. (ARWR) |
US |
$1.793B |
0.00 |
| ImmunityBio (IBRX) |
United States |
$1.774B |
0.00 |
| Travere Therapeutics (TVTX) |
United States |
$1.772B |
0.00 |
| CG Oncology, Inc. (CGON) |
US |
$1.703B |
0.00 |
| Agios Pharmaceuticals, Inc. (AGIO) |
US |
$1.634B |
0.00 |
| Arcutis Biotherapeutics, Inc. (ARQT) |
US |
$1.633B |
0.00 |
| Beam Therapeutics Inc. (BEAM) |
US |
$1.632B |
0.00 |
| Apogee Therapeutics Inc. (APGE) |
US |
$1.582B |
0.00 |
| IDEAYA Biosciences (IDYA) |
United States |
$1.555B |
0.00 |
| ANI Pharmaceuticals, Inc. (ANIP) |
US |
$1.542B |
17.44 |
| Janux Therapeutics (JANX) |
United States |
$1.511B |
0.00 |
| Edgewise Therapeutics (EWTX) |
United States |
$1.507B |
0.00 |
| Disc Medicine (IRON) |
United States |
$1.472B |
0.00 |
| Structure Therapeutics (GPCR) |
United States |
$1.452B |
0.00 |
| MannKind (MNKD) |
United States |
$1.452B |
29.88 |
| Immunocore Holdings (IMCR) |
United Kingdom |
$1.405B |
0.00 |
| Vera Therapeutics (VERA) |
United States |
$1.403B |
0.00 |
| Mesoblast (MESO) |
Australia |
$1.390B |
0.00 |
| Adaptive Biotechnologies Corporation (ADPT) |
US |
$1.338B |
0.00 |
| Dynavax Technologies (DVAX) |
United States |
$1.337B |
78.00 |
| Liquidia Technologies (LQDA) |
United States |
$1.327B |
0.00 |
| Celldex Therapeutics, Inc. (CLDX) |
US |
$1.255B |
0.00 |
| Pacira BioSciences (PCRX) |
United States |
$1.164B |
10.94 |
| GRAIL (GRAL) |
United States |
$1.135B |
0.00 |
| 89BIO (ETNB) |
United States |
$1.131B |
0.00 |
| BGM Group Ltd. (BGM) |
CN |
$1.068B |
0.00 |
| Iovance Biotherapeutics (IOVA) |
United States |
$1.035B |
0.00 |
| NeoGenomics (NEO) |
United States |
$0.990B |
0.00 |
| WAVE Life Sciences (WVE) |
Singapore |
$0.988B |
0.00 |
| Viridian Therapeutics (VRDN) |
United States |
$0.982B |
0.00 |
| Novavax (NVAX) |
United States |
$0.976B |
0.00 |
| MiMedx (MDXG) |
United States |
$0.976B |
23.61 |
| Anbio Biotechnology (NNNN) |
Germany |
$0.945B |
0.00 |
| Mineralys Therapeutics (MLYS) |
United States |
$0.938B |
0.00 |
| Syndax Pharmaceuticals (SNDX) |
United States |
$0.916B |
0.00 |
| Pharvaris (PHVS) |
Netherlands |
$0.880B |
0.00 |
| Arcus Biosciences (RCUS) |
United States |
$0.860B |
0.00 |
| Geron (GERN) |
United States |
$0.841B |
0.00 |
| Zymeworks (ZYME) |
United States |
$0.817B |
0.00 |
| Gyre Therapeutics (GYRE) |
United States |
$0.817B |
108.88 |
| Oculis Holding AG (OCS) |
Switzerland |
$0.799B |
0.00 |
| Vir Biotechnology (VIR) |
United States |
$0.777B |
0.00 |
| CorMedix Inc (CRMD) |
United States |
$0.757B |
50.73 |
| Spyre Therapeutics (SYRE) |
United States |
$0.754B |
0.00 |
| CureVac (CVAC) |
Germany |
$0.754B |
4.10 |
| Intellia Therapeutics (NTLA) |
United States |
$0.751B |
0.00 |
| Nurix Therapeutics (NRIX) |
United States |
$0.735B |
0.00 |
| Anavex Life Sciences Corp. (AVXL) |
US |
$0.724B |
0.00 |
| Praxis Precision Medicines (PRAX) |
United States |
$0.716B |
0.00 |
| LENZ Therapeutics (LENZ) |
United States |
$0.713B |
0.00 |
| Day One Biopharmaceuticals (DAWN) |
United States |
$0.708B |
0.00 |
| Nuvation Bio (NUVB) |
United States |
$0.708B |
0.00 |
| Niagen Bioscience (NAGE) |
United States |
$0.687B |
218.25 |
| ArriVent BioPharma, Inc. (AVBP) |
US |
$0.674B |
0.00 |
| Rocket Pharmaceuticals (RCKT) |
United States |
$0.674B |
0.00 |
| Myriad Genetics (MYGN) |
United States |
$0.670B |
0.00 |
| Immunome (IMNM) |
United States |
$0.663B |
0.00 |
| Trevi Therapeutics (TRVI) |
United States |
$0.657B |
0.00 |
| Bicara Therapeutics Inc. (BCAX) |
US |
$0.648B |
0.00 |
| Sinovac Biotech (SVA) |
China |
$0.645B |
0.00 |
| Dianthus Therapeutics (DNTH) |
United States |
$0.641B |
0.00 |
| Arbutus Biopharma Corporation (ABUS) |
US |
$0.630B |
0.00 |
| UniQure (QURE) |
Netherlands |
$0.629B |
0.00 |
| Basilea Pharmaceutica AG (BPMUF) |
CH |
$0.626B |
0.00 |
| Zhengye Biotechnology Holding (ZYBT) |
China |
$0.619B |
0.00 |
| Pharming Group (PHAR) |
Netherlands |
$0.615B |
0.00 |
| Pharming Group (PHGUF) |
Netherlands |
$0.613B |
0.00 |
| AbCellera Biologics Inc. (ABCL) |
CA |
$0.600B |
0.00 |
| AnaptysBio, Inc. (ANAB) |
US |
$0.578B |
0.00 |
| Replimune (REPL) |
United States |
$0.578B |
0.00 |
| Sionna Therapeutics (SION) |
United States |
$0.563B |
0.00 |
| Keros Therapeutics (KROS) |
United States |
$0.559B |
0.00 |
| Immatics (IMTX) |
Germany |
$0.558B |
32.79 |
| Bicycle Therapeutics PLC Sponsored ADR (BCYC) |
GB |
$0.538B |
0.00 |
| Cogent Biosciences, Inc. (COGT) |
US |
$0.537B |
0.00 |
| Tyra Biosciences (TYRA) |
United States |
$0.531B |
0.00 |
| GH Research (GHRS) |
Ireland |
$0.525B |
0.00 |
| Opthea (OPT) |
Australia |
$0.525B |
0.00 |
| Kura Oncology (KURA) |
United States |
$0.501B |
0.00 |
| Fortrea Holdings (FTRE) |
United States |
$0.499B |
16.21 |
| Arvinas, Inc. (ARVN) |
US |
$0.487B |
0.00 |
| Castle Biosciences (CSTL) |
United States |
$0.480B |
32.59 |
| Stoke Therapeutics (STOK) |
United States |
$0.478B |
0.00 |
| Mind Medicine (MindMed) (MNMD) |
United States |
$0.476B |
0.00 |
| Cytek Biosciences (CTKB) |
United States |
$0.470B |
0.00 |
| MeiraGTx Holdings (MGTX) |
United States |
$0.469B |
0.00 |
| Cullinan Therapeutics, Inc. (CGEM) |
US |
$0.454B |
0.00 |
| Urogen Pharma (URGN) |
United States |
$0.447B |
0.00 |
| Eton Pharmaceuticals (ETON) |
United States |
$0.446B |
0.00 |
| Upstream Bio (UPB) |
United States |
$0.441B |
0.00 |
| EYEPOINT PHARMACEUTICALS, INC (EYPT) |
United States |
$0.430B |
0.00 |
| Sage Therapeutics (SAGE) |
United States |
$0.430B |
0.00 |
| Abivax SA Sponsored ADR (ABVX) |
FR |
$0.420B |
0.00 |
| PureTech Health (PRTC) |
United States |
$0.418B |
0.00 |
| Oxford BioMedica (OXBDF) |
United Kingdom |
$0.416B |
0.00 |
| Precigen (PGEN) |
United States |
$0.412B |
0.00 |
| Maze Therapeutics (MAZE) |
United States |
$0.399B |
0.00 |
| REGENXBIO (RGNX) |
United States |
$0.397B |
0.00 |
| Prothena (PRTA) |
Ireland |
$0.396B |
0.00 |
| Northwest Biotherapeutics (NWBO) |
United States |
$0.395B |
0.00 |
| Sana Biotechnology (SANA) |
United States |
$0.386B |
0.00 |
| Celcuity, Inc. (CELC) |
US |
$0.385B |
0.00 |
| Kamada (KMDA) |
Israel |
$0.382B |
25.58 |
| Rapport Therapeutics (RAPP) |
United States |
$0.379B |
0.00 |
| Zenas BioPharma (ZBIO) |
United States |
$0.378B |
0.00 |
| Ginkgo Bioworks Holdings (DNA) |
United States |
$0.374B |
0.00 |
| Mereo BioPharma Group - (MREO) |
United Kingdom |
$0.370B |
0.00 |
| MBX Biosciences (MBX) |
United States |
$0.362B |
0.00 |
| Oric Pharmaceuticals (ORIC) |
United States |
$0.358B |
0.00 |
| Erasca (ERAS) |
United States |
$0.354B |
0.00 |
| Tectonic Therapeutic (TECX) |
United States |
$0.353B |
0.00 |
| Checkpoint Therapeutics, Inc. (CKPT) |
US |
$0.348B |
0.00 |
| Absci Corporation (ABSI) |
US |
$0.339B |
0.00 |
| Verastem (VSTM) |
United States |
$0.336B |
0.00 |
| Autolus Therapeutics PLC Sponsored ADR (AUTL) |
GB |
$0.327B |
0.00 |
| Benitec Biopharma Limited (BNTC) |
US |
$0.318B |
0.00 |
| Alpha Teknova (TKNO) |
United States |
$0.317B |
0.00 |
| Entrada Therapeutics (TRDA) |
United States |
$0.316B |
4.36 |
| Olema Pharmaceuticals (OLMA) |
United States |
$0.314B |
0.00 |
| Arcturus Therapeutics Holdings Inc. (ARCT) |
US |
$0.297B |
0.00 |
| Prima BioMed (IMMP) |
Australia |
$0.296B |
0.00 |
| Fulcrum Therapeutics (FULC) |
United States |
$0.289B |
0.00 |
| Septerna (SEPN) |
United States |
$0.287B |
0.00 |
| MaxCyte (MXCT) |
United States |
$0.283B |
0.00 |
| aTyr Pharma, Inc. (ATYR) |
US |
$0.281B |
0.00 |
| XOMA Royalty (XOMA) |
United States |
$0.275B |
0.00 |
| Cartesian Therapeutics (RNAC) |
United States |
$0.274B |
0.00 |
| 2seventy Bio (TSVT) |
United States |
$0.266B |
0.00 |
| Terns Pharmaceuticals (TERN) |
United States |
$0.263B |
0.00 |
| Allogene Therapeutics, Inc. (ALLO) |
US |
$0.262B |
0.00 |
| Solid Biosciences (SLDB) |
United States |
$0.261B |
0.00 |
| Emergent Biosolutions (EBS) |
United States |
$0.260B |
0.00 |
| Vanda Pharmaceuticals (VNDA) |
United States |
$0.258B |
0.00 |
| Lifecore Biomedical (LFCR) |
United States |
$0.257B |
0.00 |
| DBV Technologies S.A (DBVT) |
France |
$0.257B |
0.00 |
| Abeona Therapeutics Inc. (ABEO) |
US |
$0.257B |
0.00 |
| Monte Rosa Therapeutics (GLUE) |
United States |
$0.254B |
0.00 |
| ITeos Therapeutics (ITOS) |
United States |
$0.253B |
0.00 |
| Palvella Therapeutics (PVLA) |
United States |
$0.253B |
0.00 |
| Aura Biosciences, Inc. (AURA) |
US |
$0.250B |
0.00 |
| Astria Therapeutics, Inc. (ATXS) |
US |
$0.249B |
0.00 |
| Gossamer Bio (GOSS) |
United States |
$0.248B |
0.00 |
| ACELYRIN, INC (SLRN) |
United States |
$0.244B |
0.00 |
| Compass Therapeutics, Inc. (CMPX) |
US |
$0.243B |
0.00 |
| Cidara Therapeutics, Inc. (CDTX) |
US |
$0.238B |
0.00 |
| Monopar Therapeutics (MNPR) |
United States |
$0.237B |
0.00 |
| Lexicon Pharmaceuticals (LXRX) |
United States |
$0.237B |
0.00 |
| BioStem Technologies, Inc. (BSEM) |
|
$0.234B |
9.33 |
| Third Harmonic Bio (THRD) |
United States |
$0.232B |
0.00 |
| Atea Pharmaceuticals, Inc. (AVIR) |
US |
$0.232B |
0.00 |
| GENFIT S.A (GNFT) |
France |
$0.231B |
0.00 |
| Aardvark Therapeutics, Inc. (AARD) |
US |
$0.231B |
0.00 |
| Corvus Pharmaceuticals (CRVS) |
United States |
$0.228B |
0.00 |
| Rezolute (RZLT) |
United States |
$0.228B |
0.00 |
| Alumis Inc. (ALMS) |
US |
$0.226B |
0.00 |
| Candel Therapeutics, Inc. (CADL) |
US |
$0.224B |
0.00 |
| Foghorn Therapeutics (FHTX) |
United States |
$0.222B |
0.00 |
| Adocia (ADOCY) |
FR |
$0.213B |
0.00 |
| Nuvectis Pharma (NVCT) |
United States |
$0.212B |
0.00 |
| Amarin Corporation PLC (AMRN) |
IE |
$0.211B |
0.00 |
| Ocugen (OCGN) |
United States |
$0.209B |
0.00 |
| Anika Therapeutics Inc. (ANIK) |
US |
$0.208B |
0.00 |
| Design Therapeutics (DSGN) |
United States |
$0.206B |
0.00 |
| Bright Minds Biosciences (DRUG) |
United States |
$0.204B |
0.00 |
| Kodiak Sciences (KOD) |
United States |
$0.200B |
0.00 |
| Semper Paratus Acquisition (TVGN) |
United States |
$0.193B |
0.00 |
| Humacyte (HUMA) |
United States |
$0.191B |
0.00 |
| Codexis, Inc. (CDXS) |
US |
$0.189B |
0.00 |
| Innate Pharma S.A (IPHA) |
France |
$0.189B |
0.00 |
| CARGO Therapeutics (CRGX) |
United States |
$0.188B |
0.00 |
| EnGene Holdings (ENGN) |
Canada |
$0.188B |
0.00 |
| Neurogene (NGNE) |
United States |
$0.186B |
0.00 |
| Annexon, Inc. (ANNX) |
US |
$0.185B |
0.00 |
| Actuate Therapeutics, Inc. (ACTU) |
US |
$0.182B |
0.00 |
| Inventiva S.A (IVA) |
France |
$0.181B |
0.00 |
| Inhibrx Biosciences (INBX) |
United States |
$0.180B |
0.00 |
| Voyager Therapeutics (VYGR) |
United States |
$0.180B |
0.00 |
| Tiziana Life Sciences (TLSA) |
United Kingdom |
$0.175B |
0.00 |
| Y-mAbs Therapeutics (YMAB) |
United States |
$0.175B |
0.00 |
| Prime Medicine (PRME) |
United States |
$0.174B |
0.00 |
| Eledon Pharmaceuticals (ELDN) |
United States |
$0.172B |
0.00 |
| Cardiff Oncology (CRDF) |
United States |
$0.170B |
0.00 |
| Phathom Pharmaceuticals (PHAT) |
United States |
$0.168B |
0.00 |
| AC Immune (ACIU) |
CH |
$0.167B |
0.00 |
| Adherex Technologies (FENC) |
United States |
$0.166B |
0.00 |
| Molecular Partners AG (MOLN) |
Switzerland |
$0.165B |
0.00 |
| ProQR Therapeutics (PRQR) |
Netherlands |
$0.164B |
0.00 |
| INmune Bio (INMB) |
United States |
$0.164B |
0.00 |
| TuHURA Biosciences (HURA) |
United States |
$0.163B |
0.00 |
| Galena Biopharma (SLS) |
United States |
$0.163B |
0.00 |
| Puma Biotechnology (PBYI) |
United States |
$0.148B |
4.89 |
| BioAge Labs, Inc. (BIOA) |
US |
$0.146B |
0.00 |
| Eupraxia Pharmaceuticals (EPRX) |
Canada |
$0.146B |
0.00 |
| Sangamo Therapeutics (SGMO) |
United States |
$0.140B |
0.00 |
| Tango Therapeutics (TNGX) |
United States |
$0.136B |
0.00 |
| Nkarta (NKTX) |
United States |
$0.132B |
0.00 |
| Theratechnologies (THTX) |
Canada |
$0.126B |
0.00 |
| ADC Therapeutics SA (ADCT) |
CH |
$0.126B |
0.00 |
| Greenwich LifeSciences (GLSI) |
United States |
$0.125B |
0.00 |
| Cuprina Holdings (Cayman) (CUPR) |
Singapore |
$0.121B |
0.00 |
| Alpha Cognition Inc. (ACOG) |
CA |
$0.120B |
0.00 |
| Vigil Neuroscience (VIGL) |
United States |
$0.118B |
0.00 |
| ScPharmaceuticals (SCPH) |
United States |
$0.115B |
0.00 |
| Seer (SEER) |
United States |
$0.113B |
0.00 |
| Compugen Ltd. (CGEN) |
IL |
$0.112B |
0.00 |
| Editas Medicine (EDIT) |
United States |
$0.111B |
0.00 |
| Fate Therapeutics (FATE) |
United States |
$0.110B |
0.00 |
| Coherus BioSciences, Inc. (CHRS) |
US |
$0.110B |
0.00 |
| Neumora Therapeutics (NMRA) |
United States |
$0.109B |
0.00 |
| InflaRx (IFRX) |
Germany |
$0.108B |
0.00 |
| Rapt Therapeutics (RAPT) |
United States |
$0.107B |
0.00 |
| C4 Therapeutics, Inc. (CCCC) |
US |
$0.107B |
0.00 |
| BioHarvest Sciences Inc. (BHST) |
CA |
$0.105B |
0.00 |
| Immunic (IMUX) |
United States |
$0.103B |
0.00 |
| Alector, Inc. (ALEC) |
US |
$0.102B |
0.00 |
| Sagimet Biosciences (SGMT) |
United States |
$0.100B |
0.00 |
| Contineum Therapeutics (CTNM) |
United States |
$0.099B |
0.00 |
| Entera Bio (ENTX) |
Israel |
$0.099B |
0.00 |
| Coya Therapeutics (COYA) |
United States |
$0.097B |
0.00 |
| HilleVax (HLVX) |
United States |
$0.094B |
0.00 |
| Orchestra BioMed Holdings (OBIO) |
United States |
$0.093B |
0.00 |
| EXoZymes (EXOZ) |
United States |
$0.090B |
0.00 |
| Zentalis Pharmaceuticals (ZNTL) |
United States |
$0.090B |
0.00 |
| Genelux (GNLX) |
United States |
$0.088B |
0.00 |
| Black Diamond Therapeutics, Inc. (BDTX) |
US |
$0.088B |
0.00 |
| Pliant Therapeutics (PLRX) |
United States |
$0.088B |
0.00 |
| Kyverna Therapeutics (KYTX) |
United States |
$0.087B |
0.00 |
| Ventyx Biosciences (VTYX) |
United States |
$0.086B |
0.00 |
| Senti Biosciences (SNTI) |
United States |
$0.086B |
0.00 |
| Cellectis S.A. (CLLS) |
FR |
$0.085B |
0.00 |
| XBiotech (XBIT) |
United States |
$0.085B |
0.00 |
| Nautilus Biotechnology (NAUT) |
United States |
$0.084B |
0.00 |
| ANIXA BIOSCIENCES INC (ANIX) |
US |
$0.084B |
0.00 |
| Zura Bio (ZURA) |
United States |
$0.083B |
0.00 |
| Instil Bio (TIL) |
United States |
$0.083B |
0.00 |
| Elicio Therapeutics (ELTX) |
United States |
$0.082B |
0.00 |
| Climb Bio, Inc. (CLYM) |
US |
$0.082B |
0.00 |
| CervoMed (CRVO) |
United States |
$0.082B |
0.00 |
| Inozyme Pharma (INZY) |
United States |
$0.081B |
0.00 |
| Sutro Biopharma (STRO) |
United States |
$0.080B |
0.00 |
| CytomX Therapeutics (CTMX) |
United States |
$0.078B |
2.54 |
| Genenta Science S.p.A (GNTA) |
Italy |
$0.078B |
0.00 |
| Adaptimmune Therapeutics PLC (ADAP) |
GB |
$0.077B |
0.00 |
| TScan Therapeutics (TCRX) |
United States |
$0.077B |
0.00 |
| Elutia (ELUT) |
United States |
$0.077B |
0.00 |
| Adagene Inc. Sponsored ADR (ADAG) |
CN |
$0.075B |
0.00 |
| Seres Therapeutics (MCRB) |
United States |
$0.075B |
0.00 |
| Cyclacel Pharmaceuticals (CYCC) |
United States |
$0.073B |
0.00 |
| I-Mab (IMAB) |
United States |
$0.073B |
0.00 |
| MediciNova (MNOV) |
United States |
$0.073B |
0.00 |
| Jasper Therapeutics (JSPR) |
United States |
$0.071B |
0.00 |
| Vor Biopharma (VOR) |
|
$0.071B |
0.00 |
| IO Biotech (IOBT) |
Denmark |
$0.070B |
0.00 |
| Caribou Biosciences (CRBU) |
United States |
$0.070B |
0.00 |
| IGM Biosciences (IGMS) |
United States |
$0.070B |
0.00 |
| Adlai Nortye Ltd. Sponsored ADR (ANL) |
KY |
$0.069B |
0.00 |
| VTv Therapeutics (VTVT) |
United States |
$0.069B |
0.00 |
| BeyondSpring Inc. (BYSI) |
US |
$0.069B |
0.00 |
| Milestone Pharmaceuticals (MIST) |
Canada |
$0.068B |
0.00 |
| Exicure (XCUR) |
United States |
$0.066B |
0.00 |
| Clearside Biomedical, Inc. (CLSD) |
US |
$0.066B |
0.00 |
| Biomea Fusion, Inc. (BMEA) |
US |
$0.064B |
0.00 |
| Prenetics Global (PRE) |
Hong Kong, SAR China |
$0.064B |
0.00 |
| Invivyd (IVVD) |
United States |
$0.063B |
0.00 |
| Inovio Pharmaceuticals (INO) |
United States |
$0.063B |
0.00 |
| Adverum Biotechnologies, Inc. (ADVM) |
US |
$0.063B |
0.00 |
| Agenus Inc. (AGEN) |
US |
$0.062B |
0.00 |
| Citius Oncology (CTOR) |
United States |
$0.062B |
0.00 |
| Rani Therapeutics Holdings (RANI) |
United States |
$0.062B |
0.00 |
| VistaGen Therapeutics (VTGN) |
United States |
$0.062B |
0.00 |
| ZIVO Bioscience (ZIVO) |
United States |
$0.061B |
0.00 |
| Achilles Therapeutics PLC Sponsored ADR (ACHL) |
GB |
$0.061B |
0.00 |
| Acumen Pharmaceuticals, Inc. (ABOS) |
US |
$0.060B |
0.00 |
| Applied Therapeutics Inc. (APLT) |
US |
$0.059B |
0.00 |
| Cabaletta Bio, Inc. (CABA) |
US |
$0.059B |
0.00 |
| Alto Neuroscience, Inc. (ANRO) |
US |
$0.059B |
0.00 |
| Skye Bioscience (SKYE) |
United States |
$0.057B |
0.00 |
| Repare Therapeutics (RPTX) |
Canada |
$0.057B |
0.00 |
| Medicus Pharma (MDCX) |
United States |
$0.056B |
0.00 |
| Akoya Biosciences, Inc. (AKYA) |
US |
$0.056B |
0.00 |
| PDS Biotechnology (PDSB) |
United States |
$0.054B |
0.00 |
| Immix Biopharma (IMMX) |
United States |
$0.054B |
0.00 |
| Ikena Oncology (IKNA) |
United States |
$0.054B |
0.00 |
| Precision BioSciences (DTIL) |
United States |
$0.054B |
0.00 |
| Fortress Biotech (FBIO) |
United States |
$0.051B |
0.00 |
| Artiva Biotherapeutics, Inc. (ARTV) |
US |
$0.051B |
0.00 |
| Biodexa Pharmaceuticals PLC Unsponsored ADR (BDRX) |
GB |
$0.050B |
0.00 |
| OKYO Pharma (OKYO) |
|
$0.050B |
0.00 |
| Cue Biopharma (CUE) |
United States |
$0.046B |
0.00 |
| Quince Therapeutics (QNCX) |
United States |
$0.046B |
0.00 |
| Renovaro (RENB) |
United States |
$0.046B |
0.00 |
| Oncobiologics (OTLK) |
United States |
$0.046B |
0.00 |
| Connect Biopharma Holdings Limited Sponsored ADR (CNTB) |
US |
$0.044B |
0.00 |
| CAMP4 Therapeutics Corporation (CAMP) |
US |
$0.044B |
0.00 |
| Oncolytics Biotech (ONCY) |
Canada |
$0.044B |
0.00 |
| Anebulo Pharmaceuticals, Inc. (ANEB) |
US |
$0.044B |
0.00 |
| Kronos Bio (KRON) |
United States |
$0.043B |
0.00 |
| Atara Biotherapeutics, Inc. (ATRA) |
US |
$0.043B |
0.00 |
| Immuneering (IMRX) |
United States |
$0.043B |
0.00 |
| Opus Genetics (IRD) |
United States |
$0.042B |
0.00 |
| PepGen (PEPG) |
United States |
$0.042B |
0.00 |
| Werewolf Therapeutics (HOWL) |
United States |
$0.042B |
0.00 |
| Shattuck Labs (STTK) |
United States |
$0.042B |
0.00 |
| Forte Biosciences (FBRX) |
United States |
$0.042B |
0.00 |
| Lantern Pharma (LTRN) |
United States |
$0.041B |
0.00 |
| Tenaya Therapeutics (TNYA) |
United States |
$0.041B |
0.00 |
| Adicet Bio, Inc. (ACET) |
US |
$0.041B |
0.00 |
| Estrella Immunopharma (ESLA) |
United States |
$0.040B |
0.00 |
| Tvardi Therapeutics (TVRD) |
United States |
$0.040B |
0.00 |
| Barinthus Biotherapeutics PLC Sponsored ADR (BRNS) |
GB |
$0.040B |
0.00 |
| Celularity, Inc. (CELU) |
US |
$0.040B |
0.00 |
| Mersana Therapeutics (MRSN) |
United States |
$0.039B |
0.00 |
| Whitehawk Therapeutics (WHWK) |
United States |
$0.039B |
0.00 |
| TELA Bio (TELA) |
United States |
$0.038B |
0.00 |
| Rein Therapeutics (RNTX) |
United States |
$0.038B |
0.00 |
| RenovoRx (RNXT) |
United States |
$0.038B |
0.00 |
| AN2 Therapeutics, Inc. (ANTX) |
US |
$0.037B |
0.00 |
| Akari Therapeutics PLC (AKTX) |
GB |
$0.037B |
0.00 |
| bluebird bio, Inc. (BLUE) |
US |
$0.036B |
0.00 |
| Xilio Therapeutics (XLO) |
United States |
$0.036B |
0.00 |
| Advanced Biomed Inc. (ADVB) |
US |
$0.036B |
0.00 |
| Alterity Therapeutics Limited - Sponsored ADR (ATHE) |
AU |
$0.035B |
0.00 |
| Scilex Holding (SCLX) |
United States |
$0.034B |
0.00 |
| Boundless Bio, Inc. (BOLD) |
US |
$0.034B |
0.00 |
| FibroBiologics (FBLG) |
United States |
$0.034B |
0.00 |
| Pluri (PLUR) |
Israel |
$0.034B |
0.00 |
| Dyadic (DYAI) |
United States |
$0.034B |
0.00 |
| Spero Therapeutics (SPRO) |
United States |
$0.033B |
0.00 |
| Radiopharm Theranostics - (RADX) |
Australia |
$0.032B |
0.00 |
| LAVA Therapeutics (LVTX) |
Netherlands |
$0.031B |
0.00 |
| Femasys (FEMY) |
United States |
$0.031B |
0.00 |
| Cadrenal Therapeutics (CVKD) |
United States |
$0.030B |
0.00 |
| Kezar Life Sciences (KZR) |
United States |
$0.030B |
0.00 |
| OnKure Therapeutics (OKUR) |
United States |
$0.030B |
0.00 |
| Grace Therapeutics (GRCE) |
Canada |
$0.030B |
0.00 |
| Allakos Inc. (ALLK) |
US |
$0.030B |
0.00 |
| MiNK Therapeutics (INKT) |
United States |
$0.029B |
0.00 |
| CalciMedica Inc. (CALC) |
US |
$0.028B |
0.00 |
| Coeptis Therapeutics Holdings, Inc. (COEP) |
US |
$0.028B |
0.00 |
| Aligos Therapeutics, Inc. (ALGS) |
US |
$0.027B |
0.00 |
| BioAtla, Inc. (BCAB) |
US |
$0.026B |
0.00 |
| ALX Oncology Holdings Inc. (ALXO) |
US |
$0.026B |
0.00 |
| Dare Bioscience (DARE) |
United States |
$0.026B |
0.00 |
| Generation Bio (GBIO) |
United States |
$0.025B |
0.00 |
| Quantum Biopharma (QNTM) |
Canada |
$0.025B |
0.00 |
| Kalaris Therapeutics (KLRS) |
United States |
$0.024B |
0.00 |
| Clene Inc. (CLNN) |
US |
$0.023B |
0.00 |
| Annovis Bio, Inc. (ANVS) |
US |
$0.022B |
0.00 |
| KALA BIO (KALA) |
United States |
$0.022B |
0.00 |
| Tenax Therapeutics (TENX) |
United States |
$0.022B |
0.00 |
| Cognition Therapeutics, Inc. (CGTX) |
US |
$0.022B |
0.00 |
| Longeveron (LGVN) |
United States |
$0.022B |
0.00 |
| CollPlant Biotechnologies Ltd. Sponsored ADR (CLGN) |
IL |
$0.021B |
0.00 |
| ABVC BioPharma, Inc. (ABVC) |
US |
$0.021B |
0.00 |
| Passage Bio (PASG) |
United States |
$0.021B |
0.00 |
| Cardio Diagnostics Holdings, Inc. (CDIO) |
US |
$0.021B |
0.00 |
| Ovid Therapeutics (OVID) |
United States |
$0.020B |
0.00 |
| MIRA Pharmaceuticals (MIRA) |
United States |
$0.020B |
0.00 |
| Elevation Oncology (ELEV) |
United States |
$0.020B |
0.00 |
| Lisata Therapeutics (LSTA) |
United States |
$0.020B |
0.00 |
| Lexaria Bioscience (LEXX) |
Canada |
$0.019B |
0.00 |
| Promis Neurosciences (PMN) |
Canada |
$0.019B |
0.00 |
| Q32 Bio (QTTB) |
United States |
$0.019B |
0.00 |
| X4 Pharmaceuticals (XFOR) |
United States |
$0.019B |
0.00 |
| Curis (CRIS) |
United States |
$0.019B |
0.00 |
| HOOKIPA Pharma (HOOK) |
United States |
$0.018B |
0.00 |
| Chemomab Therapeutics Ltd. Sponsored ADR (CMMB) |
IL |
$0.018B |
0.00 |
| Allarity Therapeutics, Inc. (ALLR) |
US |
$0.018B |
0.00 |
| Beyond Air (XAIR) |
United States |
$0.017B |
0.00 |
| Edesa Biotech (EDSA) |
Canada |
$0.016B |
0.00 |
| Aspire Biopharma Holdings, Inc. (ASBP) |
US |
$0.016B |
0.00 |
| UNITY Biotechnology (UBX) |
United States |
$0.016B |
0.00 |
| Cingulate Inc. (CING) |
US |
$0.016B |
0.00 |
| SAB Biotherapeutics (SABS) |
United States |
$0.016B |
0.00 |
| Gelteq (GELS) |
Australia |
$0.015B |
0.00 |
| Moleculin Biotech (MBRX) |
United States |
$0.014B |
0.00 |
| GeoVax Labs (GOVX) |
United States |
$0.014B |
0.00 |
| NeuroSense Therapeutics (NRSN) |
Israel |
$0.014B |
0.00 |
| Leap Therapeutics (LPTX) |
United States |
$0.014B |
0.00 |
| Synlogic (SYBX) |
United States |
$0.014B |
0.00 |
| Bolt Biotherapeutics, Inc. (BOLT) |
US |
$0.014B |
0.00 |
| Biorestorative Therapies, Inc. (BRTX) |
US |
$0.014B |
0.00 |
| BioCardia, Inc. (BCDA) |
US |
$0.014B |
0.00 |
| IN8bio (INAB) |
United States |
$0.013B |
0.00 |
| Equillium (EQ) |
United States |
$0.013B |
0.00 |
| Rallybio (RLYB) |
United States |
$0.012B |
0.00 |
| NextCure (NXTC) |
United States |
$0.012B |
0.00 |
| Hoth Therapeutics (HOTH) |
United States |
$0.012B |
0.00 |
| Imunon (IMNN) |
United States |
$0.012B |
0.00 |
| BRIACELL THERAP (BCTX) |
CA |
$0.012B |
0.00 |
| COSCIENS Biopharma (CSCI) |
Canada |
$0.012B |
0.00 |
| Abpro Holdings Inc. (ABP) |
US |
$0.012B |
0.00 |
| Bionano Genomics, Inc. (BNGO) |
US |
$0.011B |
0.00 |
| IMMURON (IMRN) |
Australia |
$0.011B |
0.00 |
| Affimed N.V. (AFMD) |
DE |
$0.011B |
0.00 |
| LakeShore Biopharma (LSB) |
China |
$0.011B |
0.00 |
| Sensei Biotherapeutics (SNSE) |
United States |
$0.010B |
0.00 |
| Cyclerion Therapeutics (CYCN) |
United States |
$0.010B |
0.00 |
| Athira Pharma, Inc. (ATHA) |
US |
$0.009B |
0.00 |
| Aprea Therapeutics, Inc. (APRE) |
US |
$0.009B |
0.00 |
| Portage Biotech (PRTG) |
|
$0.009B |
0.00 |
| Neuphoria Therapeutics (NEUP) |
Australia |
$0.009B |
0.00 |
| Dogwood Therapeutics (DWTX) |
United States |
$0.009B |
0.00 |
| Intensity Therapeutics (INTS) |
United States |
$0.009B |
0.00 |
| Silexion Therapeutics Corp (SLXN) |
Israel |
$0.008B |
0.00 |
| Creative Medical Technology Holdings, Inc. (CELZ) |
US |
$0.008B |
0.00 |
| BioXcel Therapeutics, Inc. (BTAI) |
US |
$0.008B |
0.00 |
| IBio (IBIO) |
United States |
$0.008B |
0.00 |
| Aerovate Therapeutics (JBIO) |
United States |
$0.008B |
0.00 |
| Acurx Pharmaceuticals, Inc. (ACXP) |
US |
$0.008B |
0.00 |
| Brainstorm Cell Therapeutics Inc. (BCLI) |
US |
$0.008B |
0.00 |
| Turnstone Biologics (TSBX) |
United States |
$0.008B |
0.00 |
| HCW Biologics (HCWB) |
United States |
$0.008B |
0.00 |
| Aytu BioPharma Inc. (AYTU) |
US |
$0.007B |
0.00 |
| GENPREX (GNPX) |
United States |
$0.007B |
0.00 |
| Biofrontera Inc. (BFRI) |
US |
$0.007B |
0.00 |
| Apollomics Inc. (APLM) |
US |
$0.006B |
0.00 |
| MetaVia (MTVA) |
United States |
$0.006B |
0.00 |
| Lipella Pharmaceuticals (LIPO) |
United States |
$0.006B |
0.00 |
| Soligenix (SNGX) |
United States |
$0.006B |
0.00 |
| Evogene (EVGN) |
Israel |
$0.006B |
0.00 |
| GT Biopharma (GTBP) |
United States |
$0.006B |
0.00 |
| Avalon GloboCare Corp. (ALBT) |
US |
$0.006B |
0.00 |
| Arcadia Biosciences (RKDA) |
United States |
$0.006B |
0.00 |
| Mainz Biomed (MYNZ) |
Germany |
$0.006B |
0.00 |
| 180 Life Sciences Corp. (ATNF) |
US |
$0.006B |
0.00 |
| Dermata Therapeutics (DRMA) |
United States |
$0.005B |
0.00 |
| Pasithea Therapeutics (KTTA) |
United States |
$0.005B |
0.00 |
| Onconetix (ONCO) |
United States |
$0.004B |
0.00 |
| Adial Pharmaceuticals, Inc. (ADIL) |
US |
$0.004B |
0.00 |
| Sonnet BioTherapeutics Holdings (SONN) |
United States |
$0.004B |
0.00 |
| Alzamend Neuro, Inc. (ALZN) |
US |
$0.004B |
0.00 |
| Galecto (GLTO) |
Denmark |
$0.004B |
0.00 |
| bioAffinity Technologies, Inc. (BIAF) |
US |
$0.004B |
0.00 |
| Mustang Bio (MBIO) |
United States |
$0.004B |
0.00 |
| Lixte Biotechnology Holdings (LIXT) |
United States |
$0.004B |
0.00 |
| Palisade Bio (PALI) |
United States |
$0.004B |
0.00 |
| Silo Pharma (SILO) |
United States |
$0.004B |
0.00 |
| Tharimmune (THAR) |
United States |
$0.004B |
0.00 |
| VivoSim Labs (VIVS) |
United States |
$0.004B |
0.00 |
| Ensysce Biosciences (ENSC) |
United States |
$0.004B |
0.00 |
| Sunshine Biopharma (SBFM) |
United States |
$0.004B |
0.00 |
| Hepion Pharmaceuticals (HEPA) |
United States |
$0.004B |
0.00 |
| Titan Pharmaceuticals (TTNP) |
United States |
$0.004B |
0.00 |
| Synaptogenix (SNPX) |
United States |
$0.003B |
0.00 |
| Artelo Biosciences, Inc. (ARTL) |
US |
$0.003B |
0.00 |
| CNS Pharmaceuticals, Inc. (CNSP) |
US |
$0.003B |
0.00 |
| Windtree Therapeutics (WINT) |
United States |
$0.003B |
0.00 |
| Virax Biolabs Group (VRAX) |
United Kingdom |
$0.003B |
0.00 |
| Novogen (KZIA) |
Australia |
$0.003B |
0.00 |
| Polyrizon (PLRZ) |
Israel |
$0.003B |
0.00 |
| Enveric Biosciences (ENVB) |
United States |
$0.003B |
0.00 |
| Purple Biotech (PPBT) |
Israel |
$0.003B |
0.00 |
| Eyenovia (EYEN) |
United States |
$0.003B |
0.00 |
| AquaBounty Technologies, Inc. (AQB) |
US |
$0.003B |
0.00 |
| Revelation Biosciences (REVB) |
United States |
$0.003B |
0.00 |
| Scinai Immunotherapeutics (SCNI) |
Israel |
$0.003B |
0.00 |
| Psyence Biomedical (PBM) |
Canada |
$0.003B |
0.00 |
| Aptevo Therapeutics Inc. (APVO) |
US |
$0.002B |
0.00 |
| NuCana (NCNA) |
United Kingdom |
$0.002B |
0.00 |
| Bone Biologics Corp. (BBLG) |
US |
$0.002B |
0.00 |
| Evaxion Biotech (EVAX) |
Denmark |
$0.002B |
0.00 |
| Atrinsic (PTIX) |
United States |
$0.002B |
0.00 |
| Entero Therapeutics (ENTO) |
United States |
$0.002B |
0.00 |
| ZyVersa Therapeutics (ZVSA) |
United States |
$0.001B |
0.00 |
| NAYA Biosciences (IVF) |
United States |
$0.001B |
0.00 |
| GRI Bio (GRI) |
United States |
$0.001B |
0.00 |
| TFF Pharmaceuticals (TFFP) |
United States |
$0.000B |
0.00 |
| Capstone Therapeutics Corp. (CAPS) |
US |
$0.000B |
0.00 |
| Aceragen, Inc. (ACGN) |
US |
$0.000B |
0.00 |
| ARAVIVE, INC (ARAV) |
US |
$0.000B |
0.00 |
| Clovis Oncology, Inc. (CLVSQ) |
US |
$0.000B |
0.00 |
| Cocrystal Pharma, Inc. (COCP) |
US |
$0.000B |
0.00 |
| Celyad SA (CYAD) |
Belgium |
$0.000B |
0.00 |
| CytoMed Therapeutics (GDTC) |
Singapore |
$0.000B |
0.00 |
| Galapagos (GLPG) |
Belgium |
$0.000B |
0.00 |
| Motif Bio Plc (MTFB) |
United Kingdom |
$0.000B |
0.00 |
| PDL BioPharma (PDLI) |
United States |
$0.000B |
0.00 |
| Pulmatrix (PULM) |
United States |
$0.000B |
0.00 |
| VectivBio Holding AG (VECT) |
Switzerland |
$0.000B |
0.00 |
